PL3727453T3 - Ciekła kompozycja jako nośnik - Google Patents

Ciekła kompozycja jako nośnik

Info

Publication number
PL3727453T3
PL3727453T3 PL18825704.2T PL18825704T PL3727453T3 PL 3727453 T3 PL3727453 T3 PL 3727453T3 PL 18825704 T PL18825704 T PL 18825704T PL 3727453 T3 PL3727453 T3 PL 3727453T3
Authority
PL
Poland
Prior art keywords
carrier
liquid composition
composition
liquid
Prior art date
Application number
PL18825704.2T
Other languages
English (en)
Inventor
Franca Ferrari
Cristina Bonferoni
Giuseppina Sandri
Luigi Maria Longo
Cristina Macelloni
Silvia Rossi
Original Assignee
Cosmo Technologies Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmo Technologies Ltd. filed Critical Cosmo Technologies Ltd.
Publication of PL3727453T3 publication Critical patent/PL3727453T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
    • A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
    • A61K49/0071—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form solution, solute
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Oncology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL18825704.2T 2017-12-22 2018-12-20 Ciekła kompozycja jako nośnik PL3727453T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17210119.8A EP3501496A1 (en) 2017-12-22 2017-12-22 Liquid delivery composition
PCT/EP2018/086424 WO2019122253A1 (en) 2017-12-22 2018-12-20 Liquid Delivery Composition

Publications (1)

Publication Number Publication Date
PL3727453T3 true PL3727453T3 (pl) 2025-07-07

Family

ID=60782071

Family Applications (1)

Application Number Title Priority Date Filing Date
PL18825704.2T PL3727453T3 (pl) 2017-12-22 2018-12-20 Ciekła kompozycja jako nośnik

Country Status (14)

Country Link
US (2) US12011483B2 (pl)
EP (3) EP3501496A1 (pl)
JP (2) JP7494116B2 (pl)
KR (2) KR20240133770A (pl)
CN (1) CN111511352A (pl)
BR (1) BR112020012519A2 (pl)
CA (1) CA3081633A1 (pl)
DK (1) DK3727453T3 (pl)
ES (1) ES3031471T3 (pl)
FI (1) FI3727453T3 (pl)
MX (2) MX2020006664A (pl)
PL (1) PL3727453T3 (pl)
RU (1) RU2020124103A (pl)
WO (1) WO2019122253A1 (pl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113557008A (zh) 2018-10-29 2021-10-26 弗劳恩霍夫应用研究促进协会 具有持续活性的四环素类络合物
WO2021247774A1 (en) * 2020-06-02 2021-12-09 The Johns Hopkins University Gel for use in gastrointestinal endoscopy and endodermal, epidermal, and other mucosal uses
CN116669717A (zh) * 2020-08-17 2023-08-29 美国人福制药公司 长效原位成型/胶凝组合物
EP4203946A4 (en) * 2020-08-31 2024-10-16 Preveceutical Medical Inc. CANNABINOID FORMULATIONS AND METHODS OF USE
LU102338B1 (en) * 2020-12-21 2022-06-21 Luxembourg Inst Science & Tech List Medium for in vitro transportation and storage of cells
WO2023018661A1 (en) * 2021-08-10 2023-02-16 Bayer Healthcare Llc Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof
WO2023018649A1 (en) * 2021-08-10 2023-02-16 Bayer Healthcare Llc Liquid formulations comprising alginic acid, pectin, and carrageenan and methods of using thereof for gastric and gastroesophageal disorders
KR20240065327A (ko) * 2021-10-05 2024-05-14 코스모 테크놀러지스 리미티드 낭염 및 원위 궤양성 대장염 치료를 위한 리파마이신의 인시츄 겔화 관장제
EP4162928A1 (en) * 2021-10-05 2023-04-12 Cosmo Technologies Ltd. Rifamycin for the treatment of pouchitis, with an in-situ gelling formulation
JP2025504173A (ja) * 2022-02-04 2025-02-06 インタクト セラピューティクス, インコーポレイテッド メサラミン薬学的製剤およびその使用法
CN116510092A (zh) * 2023-05-19 2023-08-01 西安富丞生物科技有限公司 一种辅助内镜手术的多功能温敏型水凝胶及其制备方法
CN117362107B (zh) * 2023-10-18 2025-04-18 山东农业大学 一种含有温敏嵌段共聚物开关的包膜控释肥及其制备方法
MX2023012862A (es) * 2023-10-27 2023-11-09 Mar Mariana Guerrero Composicion topica de agentes esclerosantes en portadores acuosos.
WO2025191166A1 (en) 2024-03-15 2025-09-18 Cosmo Technologies Ltd. Cannula for rectal administration of an enema and compositions for use therewith
EP4616878A1 (en) 2024-03-15 2025-09-17 Cosmo Technologies Ltd. Cannula for rectal administration of an enema and compositions for use therewith
WO2025210108A1 (en) * 2024-04-03 2025-10-09 Orocidin A/S Composition for treatment of periodontal disease and related method
WO2026119376A1 (de) 2024-12-03 2026-06-11 Verovaccines Gmbh Sedimentations-stabilisierte formulierungen für hefe-basierte vakzine

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
US5124151A (en) * 1990-08-07 1992-06-23 Mediventures Inc. Drug delivery by injection with thermo-irreversible gels
US5143731A (en) * 1990-08-07 1992-09-01 Mediventures Incorporated Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5346703A (en) * 1990-08-07 1994-09-13 Mediventures, Inc. Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US6280745B1 (en) * 1997-12-23 2001-08-28 Alliance Pharmaceutical Corp. Methods and compositions for the delivery of pharmaceutical agents and/or the prevention of adhesions
KR100509119B1 (ko) 1999-07-16 2005-08-18 주식회사 엘지생활건강 프로시아니딘 올리고머를 유효성분으로 하는 약제
JP2006225398A (ja) 2002-04-01 2006-08-31 Kaken Pharmaceut Co Ltd 塩基性線維芽細胞増殖因子含有歯科用粘稠製剤
JP4909071B2 (ja) 2003-03-24 2012-04-04 プルーローメッド, インコーポレイテッド 逆感熱性ポリマーを使用する一時的な塞栓形成
CA2574307A1 (en) * 2004-07-22 2006-02-02 Cumbre Pharmaceuticals Inc. Rifamycin derivatives for treating microbial infections
CN101137369A (zh) * 2005-02-09 2008-03-05 马库赛特公司 用于眼治疗的制剂
EP2187743B1 (en) * 2007-08-16 2014-07-30 Santen Pharmaceutical Co., Ltd Rapamycin formulations for treatment of age related macular degeneration
AU2009205314A1 (en) 2008-01-14 2009-07-23 Foamix Ltd. Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
KR101101321B1 (ko) 2008-11-03 2012-01-02 주식회사 엠씨티티 상처 치유를 위한 하이드로 겔 형태의 세포전달용 비히클 및 그 제조방법
JP6076962B2 (ja) 2011-04-01 2017-02-08 フロリダ大学 リサーチファウンデーション インコーポレイティッド 治療薬を局所送達するための感熱性を有する粘膜付着性または皮膚粘着性の浸透促進剤
RU2649807C2 (ru) * 2012-02-13 2018-04-04 Космо Текнолоджиз Лимитед Способ лечения заболеваний кишечника с присутствием по меньшей мере одного воспалительного компонента
FR2994844B1 (fr) 2012-08-31 2015-01-02 Assist Publ Hopitaux De Paris Formulation gelifiante a base de ketamine
AU2015390261A1 (en) 2015-04-08 2017-11-30 Maxinase Life Sciences Limited Bioadhesive compositions for intranasal administration of granistron
US10570152B2 (en) 2015-07-28 2020-02-25 Vyome Therapeutics Limited Antibacterial therapeutics and prophylactics
EP3173067B1 (en) 2015-11-16 2018-11-14 Istanbul Universitesi Rektorlugu Mucoadhesive buccal in situ gel formulation

Also Published As

Publication number Publication date
US12011483B2 (en) 2024-06-18
JP2021506913A (ja) 2021-02-22
RU2020124103A3 (pl) 2022-01-24
CA3081633A1 (en) 2019-06-27
CN111511352A (zh) 2020-08-07
KR102936956B1 (ko) 2026-03-10
KR20200103012A (ko) 2020-09-01
JP7810753B2 (ja) 2026-02-03
RU2020124103A (ru) 2022-01-24
US20240299551A1 (en) 2024-09-12
MX2023007117A (es) 2023-06-29
EP3501496A1 (en) 2019-06-26
MX2020006664A (es) 2020-08-31
JP2024100934A (ja) 2024-07-26
FI3727453T3 (fi) 2025-07-07
US20210154300A1 (en) 2021-05-27
EP3727453A1 (en) 2020-10-28
DK3727453T3 (da) 2025-06-23
KR20240133770A (ko) 2024-09-04
ES3031471T3 (en) 2025-07-09
BR112020012519A2 (pt) 2021-02-23
JP7494116B2 (ja) 2024-06-03
WO2019122253A1 (en) 2019-06-27
EP4574173A1 (en) 2025-06-25
EP3727453B1 (en) 2025-04-16

Similar Documents

Publication Publication Date Title
DK3394033T3 (da) Heterocykliske forbindelser som immunmodulatorer
LT3283080T (lt) C9orf72 ekspresijos moduliavimo kompozicijos
HUE041976T2 (hu) Cisztein-módosított ellenanyagokat tartalmazó konjugált vegyületek
DK3294713T5 (da) Substituerede tetrahydroquinolinonforbindelser som ror-gamma-modulatorer
DK3131902T3 (da) Forbindelser som ROR-gamma-modulatorer
EP3609871A4 (en) ARYL CYCLOPROPYL-AMINO-ISOQUINOLINYL AMIDE COMPOUNDS
DK3496551T3 (da) Flydende allulosesammensætning
IL247299B (en) Complement component c5 antibodies
DK3612519T3 (da) Phenyl-2-hydroxy-acetylamino-2-methyl-phenyl forbindelser
DK3369670T3 (da) Indlejret containerbærer
DK3221414T3 (da) Farveskiftende klæbesammensætning
DK3370804T3 (da) Patronbæreranordning
IL247140B (en) Pyrazines modulators of gpr6
PL3364770T3 (pl) Kompozycja zawierająca fazę olejową
DK3284976T3 (da) Planetbærer
DK3158847T3 (da) Bæreanordning
LT3668879T (lt) Nauji junginiai
DK3672941T3 (da) Pyridylpyridonforbindelser
EP4074283C0 (en) SUPPORT FOR SACROCOLPOPEXY
EP3724416C0 (fr) Lisse à parties détachables
DK3672962T3 (da) Morpholinylpyridonforbindelser
FR3022915B1 (fr) Composition adhesive de scellage
EP3705374A4 (en) PROMOTERS
DK3160441T3 (da) Flydende thioureylensammensætninger
LT3668853T (lt) Nauji junginiai